Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2021-02, Vol.384 (5), p.403-416
Hauptverfasser: Baden, Lindsey R, El Sahly, Hana M, Essink, Brandon, Kotloff, Karen, Frey, Sharon, Novak, Rick, Diemert, David, Spector, Stephen A, Rouphael, Nadine, Creech, C. Buddy, McGettigan, John, Khetan, Shishir, Segall, Nathan, Solis, Joel, Brosz, Adam, Fierro, Carlos, Schwartz, Howard, Neuzil, Kathleen, Corey, Larry, Gilbert, Peter, Janes, Holly, Follmann, Dean, Marovich, Mary, Mascola, John, Polakowski, Laura, Ledgerwood, Julie, Graham, Barney S, Bennett, Hamilton, Pajon, Rolando, Knightly, Conor, Leav, Brett, Deng, Weiping, Zhou, Honghong, Han, Shu, Ivarsson, Melanie, Miller, Jacqueline, Zaks, Tal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 416
container_issue 5
container_start_page 403
container_title The New England journal of medicine
container_volume 384
creator Baden, Lindsey R
El Sahly, Hana M
Essink, Brandon
Kotloff, Karen
Frey, Sharon
Novak, Rick
Diemert, David
Spector, Stephen A
Rouphael, Nadine
Creech, C. Buddy
McGettigan, John
Khetan, Shishir
Segall, Nathan
Solis, Joel
Brosz, Adam
Fierro, Carlos
Schwartz, Howard
Neuzil, Kathleen
Corey, Larry
Gilbert, Peter
Janes, Holly
Follmann, Dean
Marovich, Mary
Mascola, John
Polakowski, Laura
Ledgerwood, Julie
Graham, Barney S
Bennett, Hamilton
Pajon, Rolando
Knightly, Conor
Leav, Brett
Deng, Weiping
Zhou, Honghong
Han, Shu
Ivarsson, Melanie
Miller, Jacqueline
Zaks, Tal
description Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.
doi_str_mv 10.1056/NEJMoa2035389
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7787219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2486179867</sourcerecordid><originalsourceid>FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</originalsourceid><addsrcrecordid>eNp1kEtLw0AURgdRbK0u3UpAXI7eeWQeG6GU-qJWaLXbYTqZsSlNUpNU6L83pbXYhbO5MPdw7seH0CWBWwKxuBv2X14LS4HFTOkj1CYxY5hzEMeoDUAV5lKzFjqrqjk0j3B9ilqMMakE6DaS_RBSZ906snkSjW3w9ToqQlTPfJSNhl1MqGTRuDsa414xwTSaWOfS3J-jk2AXlb_YzQ76eOi_957w4O3xudcdYCeorLFjygalFWwSaRWknTrulZecKw0JD5I7AAeWTQVlLrZMUBsnVAFYlTTfHXS_9S5X08wnzud1aRdmWaaZLdemsKk53OTpzHwW30ZKJSnRjeB6JyiLr5WvajMvVmXeZDaUK0GkVkI2FN5SriyqqvRhf4GA2fRsDnpu-Ku_sfb0b7ENcLMFsqwyuZ9n_4h-AIChgKY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486179867</pqid></control><display><type>article</type><title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Baden, Lindsey R ; El Sahly, Hana M ; Essink, Brandon ; Kotloff, Karen ; Frey, Sharon ; Novak, Rick ; Diemert, David ; Spector, Stephen A ; Rouphael, Nadine ; Creech, C. Buddy ; McGettigan, John ; Khetan, Shishir ; Segall, Nathan ; Solis, Joel ; Brosz, Adam ; Fierro, Carlos ; Schwartz, Howard ; Neuzil, Kathleen ; Corey, Larry ; Gilbert, Peter ; Janes, Holly ; Follmann, Dean ; Marovich, Mary ; Mascola, John ; Polakowski, Laura ; Ledgerwood, Julie ; Graham, Barney S ; Bennett, Hamilton ; Pajon, Rolando ; Knightly, Conor ; Leav, Brett ; Deng, Weiping ; Zhou, Honghong ; Han, Shu ; Ivarsson, Melanie ; Miller, Jacqueline ; Zaks, Tal</creator><creatorcontrib>Baden, Lindsey R ; El Sahly, Hana M ; Essink, Brandon ; Kotloff, Karen ; Frey, Sharon ; Novak, Rick ; Diemert, David ; Spector, Stephen A ; Rouphael, Nadine ; Creech, C. Buddy ; McGettigan, John ; Khetan, Shishir ; Segall, Nathan ; Solis, Joel ; Brosz, Adam ; Fierro, Carlos ; Schwartz, Howard ; Neuzil, Kathleen ; Corey, Larry ; Gilbert, Peter ; Janes, Holly ; Follmann, Dean ; Marovich, Mary ; Mascola, John ; Polakowski, Laura ; Ledgerwood, Julie ; Graham, Barney S ; Bennett, Hamilton ; Pajon, Rolando ; Knightly, Conor ; Leav, Brett ; Deng, Weiping ; Zhou, Honghong ; Han, Shu ; Ivarsson, Melanie ; Miller, Jacqueline ; Zaks, Tal ; COVE Study Group</creatorcontrib><description>Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa2035389</identifier><identifier>PMID: 33378609</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>2019-nCoV Vaccine mRNA-1273 ; Adolescent ; Adult ; Adverse events ; Age ; Aged ; Allergies ; Cardiovascular disease ; Coronaviridae ; Coronaviruses ; COVID-19 ; COVID-19 - diagnosis ; COVID-19 - immunology ; COVID-19 - prevention &amp; control ; COVID-19 Vaccines - adverse effects ; COVID-19 Vaccines - immunology ; Disease prevention ; Disease transmission ; Drug dosages ; Drug stores ; Enrollments ; Female ; Humans ; Incidence ; Infections ; Infectious diseases ; Male ; Middle Aged ; mRNA ; Nanoparticles ; Original ; Patient Acuity ; Placebos ; R&amp;D ; Research &amp; development ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Single-Blind Method ; Spike Glycoprotein, Coronavirus ; Spike protein ; Treatment Outcome ; Vaccine efficacy ; Vaccines ; Young Adult</subject><ispartof>The New England journal of medicine, 2021-02, Vol.384 (5), p.403-416</ispartof><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2020 Massachusetts Medical Society.</rights><rights>Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</citedby><cites>FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</cites><orcidid>0000-0003-0489-0074 ; 0000-0002-2179-2436</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2035389$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa2035389$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>230,314,776,780,881,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33378609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baden, Lindsey R</creatorcontrib><creatorcontrib>El Sahly, Hana M</creatorcontrib><creatorcontrib>Essink, Brandon</creatorcontrib><creatorcontrib>Kotloff, Karen</creatorcontrib><creatorcontrib>Frey, Sharon</creatorcontrib><creatorcontrib>Novak, Rick</creatorcontrib><creatorcontrib>Diemert, David</creatorcontrib><creatorcontrib>Spector, Stephen A</creatorcontrib><creatorcontrib>Rouphael, Nadine</creatorcontrib><creatorcontrib>Creech, C. Buddy</creatorcontrib><creatorcontrib>McGettigan, John</creatorcontrib><creatorcontrib>Khetan, Shishir</creatorcontrib><creatorcontrib>Segall, Nathan</creatorcontrib><creatorcontrib>Solis, Joel</creatorcontrib><creatorcontrib>Brosz, Adam</creatorcontrib><creatorcontrib>Fierro, Carlos</creatorcontrib><creatorcontrib>Schwartz, Howard</creatorcontrib><creatorcontrib>Neuzil, Kathleen</creatorcontrib><creatorcontrib>Corey, Larry</creatorcontrib><creatorcontrib>Gilbert, Peter</creatorcontrib><creatorcontrib>Janes, Holly</creatorcontrib><creatorcontrib>Follmann, Dean</creatorcontrib><creatorcontrib>Marovich, Mary</creatorcontrib><creatorcontrib>Mascola, John</creatorcontrib><creatorcontrib>Polakowski, Laura</creatorcontrib><creatorcontrib>Ledgerwood, Julie</creatorcontrib><creatorcontrib>Graham, Barney S</creatorcontrib><creatorcontrib>Bennett, Hamilton</creatorcontrib><creatorcontrib>Pajon, Rolando</creatorcontrib><creatorcontrib>Knightly, Conor</creatorcontrib><creatorcontrib>Leav, Brett</creatorcontrib><creatorcontrib>Deng, Weiping</creatorcontrib><creatorcontrib>Zhou, Honghong</creatorcontrib><creatorcontrib>Han, Shu</creatorcontrib><creatorcontrib>Ivarsson, Melanie</creatorcontrib><creatorcontrib>Miller, Jacqueline</creatorcontrib><creatorcontrib>Zaks, Tal</creatorcontrib><creatorcontrib>COVE Study Group</creatorcontrib><title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.</description><subject>2019-nCoV Vaccine mRNA-1273</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Adverse events</subject><subject>Age</subject><subject>Aged</subject><subject>Allergies</subject><subject>Cardiovascular disease</subject><subject>Coronaviridae</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - diagnosis</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 Vaccines - adverse effects</subject><subject>COVID-19 Vaccines - immunology</subject><subject>Disease prevention</subject><subject>Disease transmission</subject><subject>Drug dosages</subject><subject>Drug stores</subject><subject>Enrollments</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>mRNA</subject><subject>Nanoparticles</subject><subject>Original</subject><subject>Patient Acuity</subject><subject>Placebos</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Single-Blind Method</subject><subject>Spike Glycoprotein, Coronavirus</subject><subject>Spike protein</subject><subject>Treatment Outcome</subject><subject>Vaccine efficacy</subject><subject>Vaccines</subject><subject>Young Adult</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kEtLw0AURgdRbK0u3UpAXI7eeWQeG6GU-qJWaLXbYTqZsSlNUpNU6L83pbXYhbO5MPdw7seH0CWBWwKxuBv2X14LS4HFTOkj1CYxY5hzEMeoDUAV5lKzFjqrqjk0j3B9ilqMMakE6DaS_RBSZ906snkSjW3w9ToqQlTPfJSNhl1MqGTRuDsa414xwTSaWOfS3J-jk2AXlb_YzQ76eOi_957w4O3xudcdYCeorLFjygalFWwSaRWknTrulZecKw0JD5I7AAeWTQVlLrZMUBsnVAFYlTTfHXS_9S5X08wnzud1aRdmWaaZLdemsKk53OTpzHwW30ZKJSnRjeB6JyiLr5WvajMvVmXeZDaUK0GkVkI2FN5SriyqqvRhf4GA2fRsDnpu-Ku_sfb0b7ENcLMFsqwyuZ9n_4h-AIChgKY</recordid><startdate>20210204</startdate><enddate>20210204</enddate><creator>Baden, Lindsey R</creator><creator>El Sahly, Hana M</creator><creator>Essink, Brandon</creator><creator>Kotloff, Karen</creator><creator>Frey, Sharon</creator><creator>Novak, Rick</creator><creator>Diemert, David</creator><creator>Spector, Stephen A</creator><creator>Rouphael, Nadine</creator><creator>Creech, C. Buddy</creator><creator>McGettigan, John</creator><creator>Khetan, Shishir</creator><creator>Segall, Nathan</creator><creator>Solis, Joel</creator><creator>Brosz, Adam</creator><creator>Fierro, Carlos</creator><creator>Schwartz, Howard</creator><creator>Neuzil, Kathleen</creator><creator>Corey, Larry</creator><creator>Gilbert, Peter</creator><creator>Janes, Holly</creator><creator>Follmann, Dean</creator><creator>Marovich, Mary</creator><creator>Mascola, John</creator><creator>Polakowski, Laura</creator><creator>Ledgerwood, Julie</creator><creator>Graham, Barney S</creator><creator>Bennett, Hamilton</creator><creator>Pajon, Rolando</creator><creator>Knightly, Conor</creator><creator>Leav, Brett</creator><creator>Deng, Weiping</creator><creator>Zhou, Honghong</creator><creator>Han, Shu</creator><creator>Ivarsson, Melanie</creator><creator>Miller, Jacqueline</creator><creator>Zaks, Tal</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0489-0074</orcidid><orcidid>https://orcid.org/0000-0002-2179-2436</orcidid></search><sort><creationdate>20210204</creationdate><title>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</title><author>Baden, Lindsey R ; El Sahly, Hana M ; Essink, Brandon ; Kotloff, Karen ; Frey, Sharon ; Novak, Rick ; Diemert, David ; Spector, Stephen A ; Rouphael, Nadine ; Creech, C. Buddy ; McGettigan, John ; Khetan, Shishir ; Segall, Nathan ; Solis, Joel ; Brosz, Adam ; Fierro, Carlos ; Schwartz, Howard ; Neuzil, Kathleen ; Corey, Larry ; Gilbert, Peter ; Janes, Holly ; Follmann, Dean ; Marovich, Mary ; Mascola, John ; Polakowski, Laura ; Ledgerwood, Julie ; Graham, Barney S ; Bennett, Hamilton ; Pajon, Rolando ; Knightly, Conor ; Leav, Brett ; Deng, Weiping ; Zhou, Honghong ; Han, Shu ; Ivarsson, Melanie ; Miller, Jacqueline ; Zaks, Tal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c627t-c38af8980440698f7abc4e8e744890d4f74c00c0a3b623c5a362a5d2800a8d0a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>2019-nCoV Vaccine mRNA-1273</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Adverse events</topic><topic>Age</topic><topic>Aged</topic><topic>Allergies</topic><topic>Cardiovascular disease</topic><topic>Coronaviridae</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - diagnosis</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 Vaccines - adverse effects</topic><topic>COVID-19 Vaccines - immunology</topic><topic>Disease prevention</topic><topic>Disease transmission</topic><topic>Drug dosages</topic><topic>Drug stores</topic><topic>Enrollments</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>mRNA</topic><topic>Nanoparticles</topic><topic>Original</topic><topic>Patient Acuity</topic><topic>Placebos</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Single-Blind Method</topic><topic>Spike Glycoprotein, Coronavirus</topic><topic>Spike protein</topic><topic>Treatment Outcome</topic><topic>Vaccine efficacy</topic><topic>Vaccines</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baden, Lindsey R</creatorcontrib><creatorcontrib>El Sahly, Hana M</creatorcontrib><creatorcontrib>Essink, Brandon</creatorcontrib><creatorcontrib>Kotloff, Karen</creatorcontrib><creatorcontrib>Frey, Sharon</creatorcontrib><creatorcontrib>Novak, Rick</creatorcontrib><creatorcontrib>Diemert, David</creatorcontrib><creatorcontrib>Spector, Stephen A</creatorcontrib><creatorcontrib>Rouphael, Nadine</creatorcontrib><creatorcontrib>Creech, C. Buddy</creatorcontrib><creatorcontrib>McGettigan, John</creatorcontrib><creatorcontrib>Khetan, Shishir</creatorcontrib><creatorcontrib>Segall, Nathan</creatorcontrib><creatorcontrib>Solis, Joel</creatorcontrib><creatorcontrib>Brosz, Adam</creatorcontrib><creatorcontrib>Fierro, Carlos</creatorcontrib><creatorcontrib>Schwartz, Howard</creatorcontrib><creatorcontrib>Neuzil, Kathleen</creatorcontrib><creatorcontrib>Corey, Larry</creatorcontrib><creatorcontrib>Gilbert, Peter</creatorcontrib><creatorcontrib>Janes, Holly</creatorcontrib><creatorcontrib>Follmann, Dean</creatorcontrib><creatorcontrib>Marovich, Mary</creatorcontrib><creatorcontrib>Mascola, John</creatorcontrib><creatorcontrib>Polakowski, Laura</creatorcontrib><creatorcontrib>Ledgerwood, Julie</creatorcontrib><creatorcontrib>Graham, Barney S</creatorcontrib><creatorcontrib>Bennett, Hamilton</creatorcontrib><creatorcontrib>Pajon, Rolando</creatorcontrib><creatorcontrib>Knightly, Conor</creatorcontrib><creatorcontrib>Leav, Brett</creatorcontrib><creatorcontrib>Deng, Weiping</creatorcontrib><creatorcontrib>Zhou, Honghong</creatorcontrib><creatorcontrib>Han, Shu</creatorcontrib><creatorcontrib>Ivarsson, Melanie</creatorcontrib><creatorcontrib>Miller, Jacqueline</creatorcontrib><creatorcontrib>Zaks, Tal</creatorcontrib><creatorcontrib>COVE Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baden, Lindsey R</au><au>El Sahly, Hana M</au><au>Essink, Brandon</au><au>Kotloff, Karen</au><au>Frey, Sharon</au><au>Novak, Rick</au><au>Diemert, David</au><au>Spector, Stephen A</au><au>Rouphael, Nadine</au><au>Creech, C. Buddy</au><au>McGettigan, John</au><au>Khetan, Shishir</au><au>Segall, Nathan</au><au>Solis, Joel</au><au>Brosz, Adam</au><au>Fierro, Carlos</au><au>Schwartz, Howard</au><au>Neuzil, Kathleen</au><au>Corey, Larry</au><au>Gilbert, Peter</au><au>Janes, Holly</au><au>Follmann, Dean</au><au>Marovich, Mary</au><au>Mascola, John</au><au>Polakowski, Laura</au><au>Ledgerwood, Julie</au><au>Graham, Barney S</au><au>Bennett, Hamilton</au><au>Pajon, Rolando</au><au>Knightly, Conor</au><au>Leav, Brett</au><au>Deng, Weiping</au><au>Zhou, Honghong</au><au>Han, Shu</au><au>Ivarsson, Melanie</au><au>Miller, Jacqueline</au><au>Zaks, Tal</au><aucorp>COVE Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2021-02-04</date><risdate>2021</risdate><volume>384</volume><issue>5</issue><spage>403</spage><epage>416</epage><pages>403-416</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Two injections of mRNA-1273, a lipid nanoparticle–encapsulated mRNA-based vaccine produced in collaboration with the NIAID that encodes the SARS-CoV-2 spike protein, conferred protection against Covid-19 illness in 94% of vaccinated patients. Adverse effects of the vaccine were mild, transient local reactions, and the incidence of systemic effects such as fever, headache, and fatigue was low.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>33378609</pmid><doi>10.1056/NEJMoa2035389</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-0489-0074</orcidid><orcidid>https://orcid.org/0000-0002-2179-2436</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2021-02, Vol.384 (5), p.403-416
issn 0028-4793
1533-4406
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7787219
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects 2019-nCoV Vaccine mRNA-1273
Adolescent
Adult
Adverse events
Age
Aged
Allergies
Cardiovascular disease
Coronaviridae
Coronaviruses
COVID-19
COVID-19 - diagnosis
COVID-19 - immunology
COVID-19 - prevention & control
COVID-19 Vaccines - adverse effects
COVID-19 Vaccines - immunology
Disease prevention
Disease transmission
Drug dosages
Drug stores
Enrollments
Female
Humans
Incidence
Infections
Infectious diseases
Male
Middle Aged
mRNA
Nanoparticles
Original
Patient Acuity
Placebos
R&D
Research & development
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Single-Blind Method
Spike Glycoprotein, Coronavirus
Spike protein
Treatment Outcome
Vaccine efficacy
Vaccines
Young Adult
title Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T13%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20Safety%20of%20the%20mRNA-1273%20SARS-CoV-2%20Vaccine&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Baden,%20Lindsey%20R&rft.aucorp=COVE%20Study%20Group&rft.date=2021-02-04&rft.volume=384&rft.issue=5&rft.spage=403&rft.epage=416&rft.pages=403-416&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa2035389&rft_dat=%3Cproquest_pubme%3E2486179867%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486179867&rft_id=info:pmid/33378609&rfr_iscdi=true